Aortic arch calcification detectable on chest X-ray films is associated with plasma diacron-reactive oxygen metabolites in patients with type 2 diabetes but without cardiovascular disease

Journal of Nippon Medical School

Volumn 80, Issue 6, 2013, Pages 410-419

  Watanabe, Kentaro ^a,b   Ohara, Makoto ^b,c   Suzuki, Tatsuya ^b   Ouchi, Motoshi ^b   Suzuki, Kazunari ^b   Hashimoto, Masao ^b   Saigusa, Taro ^b   Aoyama, Junya ^b   Nakano, Hiroshi ^b   Oba, Kenzo ^b  

^a YAMAGATA UNIVERSITY   (Japan)

^b NIPPON MEDICAL SCHOOL   (Japan)

^c SHOWA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Aortic arch calcification; Diacron reactive oxygen metabolites; Oxidative stress; Type 2 diabetes

Indexed keywords

C REACTIVE PROTEIN; CHOLESTEROL; CREATININE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PLASMINOGEN ACTIVATOR INHIBITOR 1; REACTIVE OXYGEN METABOLITE; TRIACYLGLYCEROL; URIC ACID;

ADULT; AGED; ARTERY CALCIFICATION; ARTICLE; BLOOD PRESSURE; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CROSS-SECTIONAL STUDY; FEMALE; GLOMERULUS FILTRATION RATE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; INFLAMMATION; LATEX AGGLUTINATION TEST; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OCCLUSION; OXIDATIVE STRESS; STENOSIS; THORAX RADIOGRAPHY;

AGED; AGING; AORTA, THORACIC; CALCINOSIS; CARDIOVASCULAR DISEASES; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; INFLAMMATION; LINEAR MODELS; MALE; MULTIVARIATE ANALYSIS; OXIDATIVE STRESS; RADIOGRAPHY, THORACIC; REACTIVE OXYGEN SPECIES; TIME FACTORS;

EID: 84890298227     PISSN: 13454676     EISSN: 13473409     Source Type: Journal    
DOI: 10.1272/jnms.80.410     Document Type: Article

References (48)

1. Stary HC: The development of calcium deposits in atherosclerotic lesions and their persistence after lipid regression. Am J Cardiol 2001; 88 (suppl): 16E-19E.
2. Johnson RC, Leopold JA, Loscalzo J: Vascular calcification: pathobiological mechanisms and clinical implications. Circ Res 2006; 99: 1044-1059.
3. Ostrom MP, Gopal A, Ahmadi N, et al.: Mortality incidence and the severity of coronary atherosclerosis assessed by computed tomography angiography. J Am Coll Cardiol 2008; 52: 1335-1343.
4. Raggi P, Callister TQ, Cooil B, et al.: Identification of patients at increased risk of first unheralded acute myocardial infarction by electron-beam computed tomography. Circulation 2000; 101: 850-855.
5. Budoff MJ, Shaw LJ, Liu ST, et al.: Long-term prognosis associated with coronary calcification: observations from a registry of 25,253 patients. J Am Coll Cardiol 2007; 49: 1860-1870.
6. Chen NX, Moe SM: Arterial calcification in diabetes. Curr Diab Rep 2003; 3: 28-32.
7. Tomson C: Vascular calcification in chronic renal failure. Nephron Clin Prac 2003; 93: c124-c130.
8. Dao HH, Essalihi R, Bouvet C, Moreau P: Evolution and modulation of age-related medial elastocalcinosis: impact on large artery stiffness and isolated systolic hypertension. Cardiovasc Res 2005; 66: 307-317.
9. Vlachopoulos C, Aznaouridis K, Stefanadis C: Prediction of cardiovascular events and all-cause mortality with arterial stiffness: a systematic review and meta-analysis. J Am Coll Cardiol 2010; 55: 1318-1327.
10. Odink AE, van der Lugt A, Hofman A, et al.: Risk factors for coronary, aortic arch and carotid calcification; The Rotterdam Study. J Hum Hypertens 2010; 24: 86-92.
11. Hashimoto H, Iijima K, Hashimoto M, et al.: Validity and usefulness of aortic arch calcification in chest Xray. J Atheroscler Thromb 2009; 16: 256-264.
12. Iijima K, Hashimoto H, Hashimoto M, et al.: Aortic arch calcification detectable on chest X-ray is a strong independent predictor of cardiovascular events beyond traditional risk factors. Atherosclerosis 2010; 210: 137-144.
13. Chen NX, Moe SM: Vascular calcification: pathophysiology and risk factors. Curr Hypertens Rep 2012; 14: 228-237.
14. Ridker PM, Silvertown JD: Inflammation, C-reactive protein, and atherothrombosis. J Periodontol 2008; 79 (Suppl): 1544-1551.
15. Strobel NA, Fassett RG, Marsh SA, Coombes JS: Oxidative stress biomarkers as predictors of cardiovascular disease. Int J Cardiol 2011; 147: 191-201.
16. Seino Y, Nanjo K, Tajima N, et al.: The Committee of the Japan Diabetes Society on the diagnostic criteria of diabetes mellitus. Diabetol Int 2010; 1: 2-20.
17. Ohara M, Watanabe K, Suzuki T, et al.: Improving in the fasting, but not the postprandial, glucose level is associated with reduction of plasma d-ROMs level in patients with type 2 diabetes. J Nippon Med Sch 2013; 80: 200-210.
18. Hirose H, Kawabe H, Komiya N, Saito I: Relations between serum reactive oxygen metabolites (ROMs) and various inflammatory and metabolic parameters in a Japanese population. J Atheroscler Thromb 2009; 16: 77-82.
19. Sugiura T, Dohi Y, Takase H, Yamashita S, Tanaka S, Kimura G: Increased reactive oxygen metabolites is associated with cardiovascular risk factors and vascular endothelial damage in middle-aged Japanese subjects. Vasc Health Risk Manag 2011; 7: 475-482.
20. Vassalle C, Bianchi S, Bianchi F, Landi P, Battaglia D, Carpeggiani C: Oxidative stress as a predictor of cardiovascular events in coronary artery disease patients. Clin Chem Lab Med 2012; 50: 1463-1468.
21. Kruithof EK: Regulation of plasminogen activator inhibitor type 1 gene expression by inflammatory mediators and statins. Thromb Haemost 2008; 100: 969-975.
22. Vulin AI, Stanley FM: Oxidative stress activates the plasminogen activator inhibitor type 1 (PAI-1) promoter through an AP-1 response element and cooperates with insulin for additive effects on PAI-1 transcription. J Biol Chem 2004; 279: 25172-25178.
23. Spence JD: The role of lipoprotein(a) in the formation of arterial plaques, stenoses and occlusions. Can J Cardiol 2010; 26 (Suppl A): 37A-40A.
24. Suzuki T, Oba K, Igari Y, et al.: Four-year prospective study of the influence of elevated serum lipoprotein (a) concentration on ischemic heart disease and cerebral infarction in elderly patients with type-2 diabetes. Geriatr Gernotol Int 2003; 3: 106-112.
25. Kashiwagi A, Kasuga M, Araki E, et al.: International clinical harmonization of glycated hemoglobin in Japan: From Japan Diabetes Society to National Glycohemoglobin Standardization Program values. Diabetol Int 2012; 3: 8-10.
26. Japanese Society of Hypertension Committee: The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2009). Hypertens Res 2009; 32: 3-107.
27. Committee for Epidemiology and Clinical Management of Atherosclerosis: Executive Summary of Japan Atherosclerosis Society Guideline for Diagnosis and Prevention of Atherosclerotic Cardiovascular Disease of Japanese. J Atheroscler Thromb 2007; 14: 45-50.
28. Robertson RP: Chronic oxidative stress as a central mechanism for glucose toxicity in pancreatic islet beta cells in diabetes. J Biol Chem 2004; 279: 42351-42354.
29. Paolisso G, D'Amore A, Volpe C, et al.: Evidence for a relationship between oxidative stress and insulin action in non-insulin-dependent (type II) diabetic patients. Metabolism 1994; 43: 1426-1429.
30. Matsushima S, Kinugawa S, Yokota T, et al.: Increased myocardial NAD(P)H oxidase-derived superoxide causes the exacerbation of postinfarct heart failure in type 2 diabetes. Am J Physiol Heart Circ Physiol 2009; 297: H409-H416.
31. Reuter S, Gupta SC, Chaturvedi MM, Aggarwal BB: Oxidative stress, inflammation, and cancer: how are they linked? Free Radic Biol Med 2010; 49: 1603-1616.
32. Sage AP, Tintut Y, Demer LL: Regulatory mechanisms in vascular calcification. Nat Rev Cardiol 2010; 7: 528-536.
33. Liberman M, Johnson RC, Handy DE, Loscalzo J, Leopold JA: Bone morphogenetic protein-2 activates NADPH oxidase to increase endoplasmic reticulum stress and human coronary artery smooth muscle cell calcification. Biochem Biophys Res Commun 2011; 413: 436-441.
34. Byon CH, Javed A, Dai Q, et al.: Oxidative stress induces vascular calcification through modulation of the osteogenic transcription factor Runx2 by AKT signaling. J Biol Chem 2008; 283: 15319-15327.
35. Tada Y, Yano S, Yamaguchi T, et al.: Advanced Glycation End Products-induced Vascular Calcification is Mediated by Oxidative Stress: Functional Roles of NAD(P)H-oxidase. Horm Metab Res 2012; 45: 267-272.
36. Proudfoot D, Skepper JN, Hegyi L, Bennett MR, Shanahan CM, Weissberg PL: Apoptosis regulates human vascular calcification in vitro: evidence for initiation of vascular calcification by apoptotic bodies. Circ Res 2000; 87: 1055-1062.
37. Kapustin AN, Shanahan CM: Calcium regulation of vascular smooth muscle cell-derived matrix vesicles. Trends Cardiovasc Med 2012; 22: 133-137.
38. Hsu HH, Camacho NP: Isolation of calcifiable vesicles from human atherosclerotic aortas. Atherosclerosis 1999; 143: 353-362.
39. Stoneman VE, Bennett MR: Role of apoptosis in atherosclerosis and its therapeutic implications. Clin Sci (Lond) 2004; 107: 343-354.
40. Sutra T, Morena M, Bargnoux AS, Caporiccio B, Canaud B, Cristol JP: Superoxide production: a procalcifying cell signalling event in osteoblastic differentiation of vascular smooth muscle cells exposed to calcification media. Free Radic Res 2008; 42: 789-797.
41. Tanikawa T, Okada Y, Tanikawa R, Tanaka Y: Advanced glycation end products induce calcification of vascular smooth muscle cells through RAGE_p38 MAPK. J Vasc Res 2009; 46: 572-580.
42. Winlove CP, Parker KH, Avery NC, Bailey AJ: Interactions of elastin and aorta with sugars in vitro and their effects on biochemical and physical properties. Diabetologia 1996; 39: 1131-1139.
43. Forbes JM, Cooper ME, Thallas V, et al.: Reduction of the accumulation of advanced glycation end products by ACE inhibition in experimental diabetic nephropathy. Diabetes 2002; 51: 3274-3282.
44. Shao JS, Cai J, Towler DA: Molecular mechanisms of vascular calcification: lessons learned from the aorta. Arterioscler Thromb Vasc Biol 2006; 26: 1423-1430.
45. Scialla JJ, Leonard MB, Townsend RR, et al.: Correlates of osteoprotegerin and association with aortic pulse wave velocity in patients with chronic kidney disease. Clin J Am Soc Nephrol 2011; 6: 2612-2619.
46. Mugabo Y, Li L, Renier G: The connection between C-reactive protein (CRP) and diabetic vasculopathy. Focus on preclinical findings. Curr Diabetes Rev 2010; 6: 27-34.
47. Meijer CA, Le Haen PA, van Dijk RA, et al.: Activator protein-1 (AP-1) signalling in human atherosclerosis: results of a systematic evaluation and intervention study. Clin Sci (Lond) 2012; 122: 421-428.
48. DeLoach SS, Joffe MM, Mai X, Goral S, Rosas SE: Aortic calcification predicts cardiovascular events and all-cause mortality in renal transplantation. Nephrol Dial Transplant 2009; 24: 1314-1319.